Surface Metals Inc. (CSE:SUR)

Oncternal Therapeutics Cash Flow Statement

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Net Income	-0.7	-0.89	-1.7	-3.52	-0.62	-0.26
Depreciation & Amortization	0.05	0.07	0.69	0.27	-	-
Loss (Gain) From Sale of Assets	0.11	0.08	0.01	-0.68	-	-
Stock-Based Compensation	-	-	-	2.11	0.82	-
Provision & Write-off of Bad Debts	0.02	0.02	-	-	-	-
Other Operating Activities	0.02	0.03	-0.57	-0.16	-0.75	-0.02
Change in Accounts Receivable	0.01	0.02	0.02	-0.04	-0.01	0.01
Change in Accounts Payable	0.06	-0.1	-0.16	0.14	0.15	0.15
Change in Other Net Operating Assets	0.02	0.11	-0.01	-0.06	-0.18	0.08
Operating Cash Flow	-0.4	-0.65	-1.72	-1.96	-0.59	-0.01
Capital Expenditures	-0.15	-0.52	-8.21	-2.54	-0.34	-
Sale of Property, Plant & Equipment	0.13	0.27	-	-	-	-
Cash Acquisitions	-	-	-	-	0.36	-
Sale (Purchase) of Intangibles	-	-	-	-	0	-
Other Investing Activities	-0.07	-	0.01	0.83	-0.32	-
Investing Cash Flow	-0.09	-0.25	-8.2	-1.71	-0.3	-
Short-Term Debt Issued	-	-	-	-	0.04	0.01
Total Debt Issued	-	-	-	-	0.04	0.01
Short-Term Debt Repaid	-	-	-	-	-0.09	-
Long-Term Debt Repaid	-	-0.06	-0.05	-	-	-
Total Debt Repaid	-0.06	-0.06	-0.05	-	-0.09	-
Net Debt Issued (Repaid)	-0.06	-0.06	-0.05	-	-0.05	0.01
Issuance of Common Stock	0.05	0.98	0.48	10.87	3.92	-
Other Financing Activities	-0.05	-0.05	-	-0.26	-0.18	-
Financing Cash Flow	-0.06	0.88	0.43	10.62	3.69	0.01
Foreign Exchange Rate Adjustments	-0.03	-0.01	-0.04	0.06	-	-
Net Cash Flow	-0.59	-0.04	-9.52	7.01	2.8	0
Free Cash Flow	-0.55	-1.17	-9.93	-4.5	-0.93	-0.01
Free Cash Flow Per Share	-0.02	-0.05	-0.51	-0.29	-0.12	-0.05
Levered Free Cash Flow	-0.62	-1.19	-9.41	-2.11	-0.85	0.05
Unlevered Free Cash Flow	-0.61	-1.17	-9.39	-2.11	-0.84	0.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.